IGF2BP1 and neoplasm: At the post-transcriptional level, IGF2BP1 maintains the expression of multiple SRF target genes, including PDZ and LIM domain 7 (PDLIM7) and forkhead box K1 (FOXK1), which further enhances tumor cell growth and invasion (61).